Trial Profile
Ticagrelor vs. Tirofiban, Comparison of Anti-platelet Effects in Patients With Non-ST Elevation Acute Coronary Syndrome (TE-CLOT Trial : Ticagrelor's Effect for CLOT Prevention) ; A Single Center, Open-label Randomized Controlled Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin; Tirofiban
- Indications Acute coronary syndromes; Embolism and thrombosis
- Focus Pharmacodynamics; Registrational
- Acronyms TE-CLOT
- 19 Nov 2015 Results published in the Thrombosis and Haemostasis
- 31 Mar 2014 Primary endpoint 'Platelet-aggregation' has not been met.
- 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.